Emulsion and use of the emulsion as a parenteral preparation
CA 2000395 A1 · Owner: Novo Nordisk A/S · Inventors: Hansen, Tomas T.; Godtfredsen, Sven E.; Froekjaer, Sven
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The emulsion has an aqueous, continuous phase and containing as the discontinuous phase the triglycerides 2oleyl-1,3-di(octanoyl/decanoyl) glycerol formulated for, parenteral use. This emulsion exhibits a better bicavailability than hitherto known parenteral emulsions used as a source for oleic acid.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 10, 1989. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 10, 2009.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 10, 2011.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.